A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis

NCT02545907 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Amyloidosis

Interventions

DRUG: Carfilzomib
DRUG: Thalidomide
DRUG: Dexamethasone

Sponsor

University College, London